Samsung Changwon Hospital Introduces Digital Pancreatobiliary Endoscope 'SpyGlass DS'

Accurate Diagnosis and Treatment Possible, Reduced Patient Burden Including Shortened Treatment and Hospitalization Periods

Sungkyunkwan University Samsung Changwon Hospital has introduced and is operating the most advanced high-resolution digital endoscope dedicated to the pancreatobiliary system, SpyGlass DS.

[Asia Economy Yeongnam Reporting Headquarters, Reporter Song Jong-gu] Sungkyunkwan University Samsung Changwon Hospital has introduced and is operating the most advanced dedicated high-resolution digital endoscope for the pancreatobiliary system, the SpyGlass DS (SpyGlassTM DS Direct Visualization System).

With this, Samsung Changwon Hospital can provide specialized and high-quality medical services to patients suffering from pancreatobiliary diseases in the region.

The newly introduced SpyGlass DS is a disposable digital pancreatobiliary endoscope equipped with a high-definition camera, which directly approaches the duodenal papilla to observe the inside of the bile and pancreatic ducts with clear digital video and images, enabling accurate tissue sampling and stone removal.

When performing lithotripsy by inserting the newly introduced SpyGlass DS into the bile and pancreatic ducts, treatment can be completed with a single endoscopic procedure, and the hospitalization period can also be shortened.

Additionally, while multiple procedures were previously required to remove refractory bile duct stones using conventional ERCP, treatment with SpyGlass DS reduces the number of procedures, thereby lessening the burden on patients.

Professor Kim Kwang-min of the Department of Gastroenterology at Samsung Changwon Hospital said, “With the introduction of SpyGlass DS, we can now access the pancreatobiliary system, which was previously difficult to reach. By observing the inside of the bile and pancreatic ducts with clear images and videos, accurate diagnosis and treatment are possible, and we expect to increase the early detection rate of pancreatobiliary cancer.”

This content was produced with the assistance of AI translation services.